ProShare Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Sell |
21,748
-2,583
| -11% | -$1.89K | ﹤0.01% | 2073 |
|
|
2025
Q1 | $19.6K | Sell |
24,331
-7,004
| -22% | -$5.65K | ﹤0.01% | 2039 |
|
|
2024
Q4 | $43.2K | Buy |
31,335
+3,504
| +13% | +$4.84K | ﹤0.01% | 2197 |
|
|
2024
Q3 | $28.9K | Buy |
27,831
+6,688
| +32% | +$6.96K | ﹤0.01% | 2027 |
|
|
2024
Q2 | $36.6K | Sell |
21,143
-5,520
| -21% | -$9.55K | ﹤0.01% | 1776 |
|
|
2024
Q1 | $63.7K | Buy |
26,663
+3,028
| +13% | +$7.24K | ﹤0.01% | 1874 |
|
|
2023
Q4 | $78.7K | Buy |
23,635
+4,494
| +23% | +$15K | ﹤0.01% | 1812 |
|
|
2023
Q3 | $71.6K | Buy |
19,141
+1,299
| +7% | +$4.86K | ﹤0.01% | 1681 |
|
|
2023
Q2 | $76.2K | Buy |
17,842
+2,020
| +13% | +$8.63K | ﹤0.01% | 1734 |
|
|
2023
Q1 | $108K | Sell |
15,822
-1,971
| -11% | -$13.5K | ﹤0.01% | 1579 |
|
|
2022
Q4 | $141K | Buy |
17,793
+1,381
| +8% | +$10.9K | ﹤0.01% | 1579 |
|
|
2022
Q3 | $158K | Buy |
16,412
+264
| +2% | +$2.54K | ﹤0.01% | 1457 |
|
|
2022
Q2 | $117K | Sell |
16,148
-6,260
| -28% | -$45.4K | ﹤0.01% | 1586 |
|
|
2022
Q1 | $289K | Sell |
22,408
-4,602
| -17% | -$59.4K | ﹤0.01% | 1652 |
|
|
2021
Q4 | $432K | Buy |
27,010
+819
| +3% | +$13.1K | ﹤0.01% | 1558 |
|
|
2021
Q3 | $421K | Sell |
26,191
-5,879
| -18% | -$94.5K | ﹤0.01% | 1310 |
|
|
2021
Q2 | $444K | Buy |
32,070
+4,390
| +16% | +$60.8K | ﹤0.01% | 1612 |
|
|
2021
Q1 | $404K | Buy |
27,680
+2,311
| +9% | +$33.7K | ﹤0.01% | 1597 |
|
|
2020
Q4 | $441K | Buy |
25,369
+5,616
| +28% | +$97.6K | ﹤0.01% | 1348 |
|
|
2020
Q3 | $362K | Sell |
19,753
-468
| -2% | -$8.58K | ﹤0.01% | 1075 |
|
|
2020
Q2 | $361K | Buy |
20,221
+6,911
| +52% | +$123K | ﹤0.01% | 1120 |
|
|
2020
Q1 | $216K | Sell |
13,310
-10,339
| -44% | -$168K | ﹤0.01% | 982 |
|
|
2019
Q4 | $426K | Sell |
23,649
-2,286
| -9% | -$41.2K | ﹤0.01% | 1149 |
|
|
2019
Q3 | $525K | Buy |
25,935
+190
| +0.7% | +$3.85K | ﹤0.01% | 962 |
|
|
2019
Q2 | $569K | Sell |
25,745
-3,426
| -12% | -$75.7K | ﹤0.01% | 964 |
|
|
2019
Q1 | $398K | Buy |
29,171
+646
| +2% | +$8.81K | ﹤0.01% | 1123 |
|
|
2018
Q4 | $258K | Sell |
28,525
-5,481
| -16% | -$49.6K | ﹤0.01% | 1234 |
|
|
2018
Q3 | $561K | Sell |
34,006
-363
| -1% | -$5.99K | ﹤0.01% | 1053 |
|
|
2018
Q2 | $481K | Buy |
34,369
+1,639
| +5% | +$22.9K | ﹤0.01% | 1140 |
|
|
2018
Q1 | $362K | Sell |
32,730
-4,184
| -11% | -$46.3K | ﹤0.01% | 1237 |
|
|
2017
Q4 | $325K | Buy |
36,914
+1,659
| +5% | +$14.6K | ﹤0.01% | 1343 |
|
|
2017
Q3 | $471K | Buy |
35,255
+5,540
| +19% | +$74K | ﹤0.01% | 983 |
|
|
2017
Q2 | $426K | Sell |
29,715
-1,465
| -5% | -$21K | ﹤0.01% | 1014 |
|
|
2017
Q1 | $659K | Sell |
31,180
-2,395
| -7% | -$50.6K | 0.01% | 901 |
|
|
2016
Q4 | $945K | Buy |
33,575
+2,715
| +9% | +$76.4K | 0.01% | 802 |
|
|
2016
Q3 | $826K | Sell |
30,860
-1,881
| -6% | -$50.3K | 0.01% | 740 |
|
|
2016
Q2 | $553K | Buy |
32,741
+912
| +3% | +$15.4K | 0.01% | 925 |
|
|
2016
Q1 | $676K | Sell |
31,829
-2,879
| -8% | -$61.1K | 0.01% | 870 |
|
|
2015
Q4 | $797K | Buy |
+34,708
| New | +$797K | 0.01% | 837 |
|